A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 26, Issue 8, 1999, Pages 1145-1152

  Yamaguchi, S ^a   Fukuda, M ^a   Ota, T ^a   Nakayama, Y ^a   Ogata, H ^a   Shimizu, K ^a   Nishikawa, T ^a   Adachi, Y ^a   Fukuma, E ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; TAMOXIFEN; TEGAFUR;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TAMOXIFEN; TEGAFUR; TREATMENT OUTCOME;

EID: 0033162104     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)